Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older
scientific article
Author/s
author: Sylvie Chevret, Nathalie Gachard, Stéphane de Botton, Bruno Quesnel, Claude Preudhomme, Pierre Fenaux, Hervé Dombret, Emmanuel Raffoux, Pascal Turlure, Cécile Pautas, Thierry de Revel, Aline Renneville, Nicolas Boissel, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Dominique Bordessoule
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.